HOSPITALUS: Evaluation of the Impact of Lung Ultrasound on Mortality and Rehospitalization in Patients Admitted to the Emergency Department With Dyspnea

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05787665
Collaborator
(none)
385
1
12
32

Study Details

Study Description

Brief Summary

Dyspnea is a frequent reason for referral to emergency departments, leading to a 30-day mortality rate of up to 10% and a 3-month rehospitalization rate of over 30%.

Multiple etiologies, as well as poor performance of clinical examination and chest radiography, lead to a diagnostic error rate of nearly 30% at the end of emergency department care. These diagnostic errors lead to rehospitalization and an excess mortality rate of more than 50% compared to patients with a correct initial diagnosis, which is explained in particular by the use of inappropriate therapies.

Lung ultrasound is a rapid, non-irradiating, non-invasive, inexpensive, reproducible imaging test that can be used at the bedside. It has a better diagnostic performance than chest radiography, commonly performed in emergency departments.The immediate benefit of lung ultrasound for the most common diagnoses in emergency medicine has already been demonstrated.

From an organizational point of view, a few studies have shown a benefit of lung ultrasound in reducing the time spent in emergency departments and the number of additional examinations necessary for the final diagnosis. However, there is no data in the literature on the longer term impact of its use in the emergency department.

The primary objective is to evaluate the impact of performing lung ultrasound in terms of 3-month mortality and rehospitalization as part of the diagnostic process for patients admitted to the emergency department with dyspnea.

Condition or Disease Intervention/Treatment Phase
  • Other: phone call at 3 months

Study Design

Study Type:
Observational
Anticipated Enrollment :
385 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Impact of Lung Ultrasound on Mortality and Rehospitalization in Patients Admitted to the Emergency Department With Dyspnea: a Prospective Observational Cohort
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
With Lung Ultrasonography

Patient who meet inclusions criteria, and which lung ultrasonography were performed during their medical care in Emergency Department

Other: phone call at 3 months
patients will be called at 3 months to know if they are alive and to know if they have been rehospitalized

Without Lung Ultrasonography

Patient who meet inclusions criteria, and which lung ultrasonography were not performed during their medical care in Emergency Department.

Other: phone call at 3 months
patients will be called at 3 months to know if they are alive and to know if they have been rehospitalized

Outcome Measures

Primary Outcome Measures

  1. The primary objective is to evaluate the impact of performing lung ultrasound in terms of 3-month mortality as part of the diagnostic process for patients admitted to the emergency department with dyspnea. [at 3 months]

    The primary endpoint is the rate of mortality at 3 months.

  2. The primary objective is to evaluate the impact of performing lung ultrasound in terms of 3-month rehospitalization as part of the diagnostic process for patients admitted to the emergency department with dyspnea. [at 3 months]

    the primary endpoint is the rate of rehospitalization at 3 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Admission to the emergency department with dyspnea defined by:

The functional sign of dyspnea experienced by the patient; Or a clinical sign of respiratory distress.

  • Non-opposition of the patient or patient's family if the patient isn't able
Exclusion Criteria:
  • Trauma-induced dyspnea;

  • Patient being on palliative care;

  • Patient with criteria for initial resuscitation with admission to a critical care unit;

  • Pregnant women, women in labour or nursing mothers;

  • Persons deprived of liberty by judicial or administrative decision;

  • Persons under psychiatric care;

  • Persons admitted to a health or social institution for purposes other than research;

  • Persons of full age subject to a legal protection measure (guardianship, curatorship);

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Edouard-Herriot - Emergency Department Lyon France 69003

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

  • Principal Investigator: Félix AMIOT, MD, Hospices Civils de Lyon

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT05787665
Other Study ID Numbers:
  • 69HCL23_0002
  • 2023-A00177-38
First Posted:
Mar 28, 2023
Last Update Posted:
Mar 30, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 30, 2023